Milestones :: Perspectives :: Research
COVID Vaccines Development/Procurement/Distribution/Policy – Russia, China
Russia: Sputnik V – “the first registered COVID-19 vaccine”
Sputnik V vaccine authorized in Tunisia
Press release, 30.01.2021 21:20:00
“…Tunisia has become the third country in Africa to register the vaccine. Sputnik V was approved under the emergency use authorization procedure. The approval is based on the results of the clinical trials of Sputnik V in Russia.
To date Sputnik V has been registered in Russia, Belarus, Algeria, Argentina, Bolivia, Serbia, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the UAE, Iran and the Republic of Guinea…”
Sputnik V vaccine authorized in the Republic of Guinea
Press release, 29.01.2021
“…The Republic of Guinea [National Directorate of Pharmacy and Medicine] has become the second country in Africa to register the vaccine. Sputnik V was approved under the emergency use authorization procedure…”
China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
WHO commends China for submitting COVID-19 vaccines data for assessment
The World Health Organization (WHO) commends China for submitting data of its COVID-19 vaccines to the WHO for the Emergency Use Listing procedure, a top WHO expert said on Jan 26.
There are two Chinese-made vaccines, produced by Sinopharm and Sinovac respectively, currently under WHO evaluation, said Katherine O’Brien, director of WHO’s Department of Immunization, Vaccines and Biologicals.
The data of the vaccines have been submitted to the WHO, but inspectors on the ground are still in quarantine waiting to go to the manufacturing sites for evaluation, she added.
“So there is engagement by the WHO and we will also look forward to reviewing those data through the policy process,” she said, referring to the policy review by the WHO Strategic Advisory Group of Experts on Immunization, which is a separate process from the regulatory assessment and provides recommendations on how to use the vaccines.
According to the latest WHO files, the Sinopharm vaccine is now in progress of assessment, while the Sinovac vaccine submitted its data for inspection in mid-January with more dossiers expected for submission by the end of this month. Anticipated decisions from the WHO on both vaccines are expected in March…
Chinese vaccines bring relief in global COVID-19 battle
— Chinese vaccines have been proved to protect people against COVID-19 in a safe, effective and affordable way.
— 12 foreign countries have granted market approval or emergency use for two Chinese vaccines.
— China’s vaccine producers have been required to plan and increase production capacity and contribute to vaccine accessibility and affordability in developing countries.